Rick Bierly
CIK 1604351 · CFO (former) · last filed 2017-10-16
Rick Bierly is a CFO (former) who has filed 15 SEC Form 4 insider transactions across 4 companies since 2015. The most recent filing, for OPTN, was dated Oct 16, 2017. Across all open-market trades the lifetime net is −$1.8M, making them a net seller over the disclosed history.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
MDVN price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
525 MARKET ST., 36TH FLOOR
SAN FRANCISCO, CA 94105
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| OptiNose, Inc. (OPTN) Delisted | Director | — | $9.60 | — | $0 | 1 | 2017-10-16 |
| ACRS | Director | — | $3.79 | — | $0 | 2 | 2017-06-16 |
| Impax Laboratories, LLC (IPXL) Delisted | Director | 9,270 | — | — | $0 | 2 | 2017-05-17 |
| MEDIVATION, INC. (MDVN) Delisted | CFO (former) | 35,059 | — | — | -$1.79M | 9 | 2016-05-09 |
Recent Filings
15 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2017-10-16 | OptiNose, Inc. (OPTN) Delisted | Grant (A) | — | $0 | EDGAR |
| 2017-06-16 | ACRS | Grant (A) | — | $0 | EDGAR |
| 2017-05-17 | Impax Laboratories, LLC (IPXL) Delisted | Grant (A) | +4,375 | $0 | EDGAR |
| 2016-08-22 | Impax Laboratories, LLC (IPXL) Delisted | Grant (A) | +4,895 | $0 | EDGAR |
| 2016-07-01 | ACRS | Grant (A) | — | $0 | EDGAR |
| 2016-05-09 | MEDIVATION, INC. (MDVN) Delisted | Sell (S) | −10,340 | -$617.9K | EDGAR |
| 2016-03-07 | MEDIVATION, INC. (MDVN) Delisted | Sell (S) | −2,998 | -$119.9K | EDGAR |
| 2016-03-02 | MEDIVATION, INC. (MDVN) Delisted | Grant (A) | +12,400 | $0 | EDGAR |
| 2015-10-06 | — | Grant (A) | — | $0 | |
| 2015-05-20 | MEDIVATION, INC. (MDVN) Delisted | Sell (S) | −1,000 | -$130.0K | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.